The AARP report suggests the spending cap could be huge for Medicare enrollees who take costly drugs for cancer, rheumatoid ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

Hays and her husband who have a Medicare Part D drug plan. As a result, she expects to shell out a lot less at the pharmacy ...

New AARP Report Finds Medicare Part D Enrollees Who Reach the New $2,000 Out-of-Pocket Spending Cap Will Save Thousands ...

Medicare enrollees will not have to pay more than $2,000 in out-of-pocket drug expenditures — and that could lead to huge ...

AARP offers eight Medicare supplement (Medigap) plans to members. However, members cannot purchase every plan in every state or county. You may be eligible to purchase an AARP Medicare plan if you ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Part C is a bundled plan that you would call Medicare Advantage. It is an opportunity that you have to choose what kind of Medicare program you want. You can pick your doctor as long as he or she is a ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

A new report from AARP Public Policy Institute found that the top 25 drugs prescribed under Medicare Part D have nearly ...

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...

A new report out from AARP today provides additional insight into the impact of a historic new financial protection for our nation's nearly 55 million Medicare drug plan enrollees. For the first time ...